3-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-7-fluoro-4-oxo-5-(pyridin-2-ylmethyl)imidazo[1,5-a]quinoxaline-6-carbonitrile

C24H18FN7O2 — CID 67888172

IUPAC3-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-7-fluoro-4-oxo-5-(pyridin-2-ylmethyl)imidazo[1,5-a]quinoxaline-6-carbonitrile
SMILESN#Cc1c(F)ccc2c1n(Cc1ccccn1)c(=O)c1c(-c3nc(C4CCCC4)no3)ncn12
InChIInChI=1S/C24H18FN7O2/c25-17-8-9-18-20(16(17)11-26)31(12-15-7-3-4-10-27-15)24(33)21-19(28-13-32(18)21)23-29-22(30-34-23)14-5-1-2-6-14/h3-4,7-10,13-14H,1-2,5-6,12H2
InChIKeyIPHJTTABTOIQHG-UHFFFAOYSA-N
MW455.45 g/mol
LogP3.81
Rot. Bonds4

About 3-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-7-fluoro-4-oxo-5-(pyridin-2-ylmethyl)imidazo[1,5-a]quinoxaline-6-carbonitrile

3-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-7-fluoro-4-oxo-5-(pyridin-2-ylmethyl)imidazo[1,5-a]quinoxaline-6-carbonitrile (PubChem CID 67888172) has the molecular formula C24H18FN7O2 and a molecular weight of 455.45 g/mol. Its IUPAC name is 3-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-7-fluoro-4-oxo-5-(pyridin-2-ylmethyl)imidazo[1,5-a]quinoxaline-6-carbonitrile.

Molecular Properties

Compound Name3-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-7-fluoro-4-oxo-5-(pyridin-2-ylmethyl)imidazo[1,5-a]quinoxaline-6-carbonitrile
PubChem CID67888172
Molecular FormulaC24H18FN7O2
Molecular Weight455.45 g/mol
Exact Mass455.15
IUPAC Name3-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-7-fluoro-4-oxo-5-(pyridin-2-ylmethyl)imidazo[1,5-a]quinoxaline-6-carbonitrile
SMILESN#Cc1c(F)ccc2c1n(Cc1ccccn1)c(=O)c1c(-c3nc(C4CCCC4)no3)ncn12
InChIInChI=1S/C24H18FN7O2/c25-17-8-9-18-20(16(17)11-26)31(12-15-7-3-4-10-27-15)24(33)21-19(28-13-32(18)21)23-29-22(30-34-23)14-5-1-2-6-14/h3-4,7-10,13-14H,1-2,5-6,12H2
InChIKeyIPHJTTABTOIQHG-UHFFFAOYSA-N
XLogP3.81
TPSA114.90 Ų
H-Bond Donors
H-Bond Acceptors9
Rotatable Bonds4
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500455.45
LogP ≤ 53.81
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 109

Analyze 3-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-7-fluoro-4-oxo-5-(pyridin-2-ylmethyl)imidazo[1,5-a]quinoxaline-6-carbonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-7-fluoro-4-oxo-5-(pyridin-2-ylmethyl)imidazo[1,5-a]quinoxaline-6-carbonitrile?
The IUPAC name of 3-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-7-fluoro-4-oxo-5-(pyridin-2-ylmethyl)imidazo[1,5-a]quinoxaline-6-carbonitrile (CID 67888172) is 3-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-7-fluoro-4-oxo-5-(pyridin-2-ylmethyl)imidazo[1,5-a]quinoxaline-6-carbonitrile.
What is the SMILES notation for 3-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-7-fluoro-4-oxo-5-(pyridin-2-ylmethyl)imidazo[1,5-a]quinoxaline-6-carbonitrile?
The canonical SMILES for 3-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-7-fluoro-4-oxo-5-(pyridin-2-ylmethyl)imidazo[1,5-a]quinoxaline-6-carbonitrile is N#Cc1c(F)ccc2c1n(Cc1ccccn1)c(=O)c1c(-c3nc(C4CCCC4)no3)ncn12.
What is the InChIKey of 3-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-7-fluoro-4-oxo-5-(pyridin-2-ylmethyl)imidazo[1,5-a]quinoxaline-6-carbonitrile?
The InChIKey is IPHJTTABTOIQHG-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H18FN7O2/c25-17-8-9-18-20(16(17)11-26)31(12-15-7-3-4-10-27-15)24(33)21-19(28-13-32(18)21)23-29-22(30-34-23)14-5-1-2-6-14/h3-4,7-10,13-14H,1-2,5-6,12H2.
What are the key properties of 3-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-7-fluoro-4-oxo-5-(pyridin-2-ylmethyl)imidazo[1,5-a]quinoxaline-6-carbonitrile?
3-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-7-fluoro-4-oxo-5-(pyridin-2-ylmethyl)imidazo[1,5-a]quinoxaline-6-carbonitrile has a molecular weight of 455.45 g/mol, XLogP of 3.81, 4 rotatable bonds, 0 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-7-fluoro-4-oxo-5-(pyridin-2-ylmethyl)imidazo[1,5-a]quinoxaline-6-carbonitrile is sourced from PubChem (CID 67888172), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).